The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to provide an environment that will foster communication and collaboration between investigator communities involved in complications research. The DiaComp-PTP will provide investigators with access to pilot funds to pursue additional preclinical studies of promising new therapeutics.
Recent Opportunities
| Title | FOA | Post | Expire | Purpose | |
|---|---|---|---|---|---|
NIH |
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional) | RFA-HL-24-008 | 2023-07-20 | 2023-10-12 | The purpose of this Notice of Funding Opportunity (NOFO) is to elucidate the contribution of sleep deficiency and circadian disruption to metabolic and cardiovascular pathobiology, disease trajectory, and treatment response in individuals living with Type 1 Diabetes (T1D). |
NIH |
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional) | RFA-HL-24-009 | 2023-07-20 | 2023-10-12 | This Notice of Funding Opportunity (NOFO) will support preliminary studies aimed at obtaining information necessary to guide the design of a full randomized control trial to test whether sleep and circadian targeted interventions improve the clinical course and treatment outcomes in individuals with Type 1 Diabetes (T1D). |
NIDDK |
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) | RFA-DK-23-014 | 2023-06-15 | 2023-09-29 | The NIDDK Catalyst Award is designed to complement NIDDK's traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and transformational studies in topic areas of interest to NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases, and to NIDDK's Division of Digestive Diseases and Nutrition. |
NIDDK |
Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed) | RFA-DK-23-019 | 2023-05-31 | 2023-10-27 | The purpose of this NOFO is to create a consortium to bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals with type 2 diabetes (T2D) and developing more precise definitions of disease. |
NIDDK |
Integration of Novel Measures for Improved Classification of Type 2 Diabetes – Biostatistics Research Center (U01 Clinical Trial Not Allowed) | RFA-DK-23-020 | 2023-05-31 | 2023-10-27 | This NOFO invites applications for a Biostatistics Research Center to participate in a consortium aimed at improving understanding of heterogeneity of type 2 diabetes (T2D). |
NIH |
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) | RFA-TR-23-011 | 2023-04-20 | 2023-05-23 | NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. |